HSCI iPS Core Facility

The Most Experienced iPS Cell Team in the Nation

In July 2008, the Harvard Stem Cell Institute iPS Core Facility was created to accelerate research in the stem cell field by facilitating the derivation and distribution of induced pluripotent stem cell (iPSC) lines. Disease-specific iPSC lines provide us with an opportunity to study the mechanisms of disease and ultimately to develop new treatments.

In recent years, we have refined the iPS Core to better meet investigator needs. The iPS Core now operates on a fee-for-service basis to provide investigators with access to the latest cutting-edge stem cell technologies.

All of these services are available to the global research community.

• New! We now offer differentiation of hPSCs into skeletal muscle myoblasts.
• New! We have added lipid nanoparticles (LNP RNA) as a new reprogramming method.
• New! We are pleased to offer lower rates for gene editing as of July 1st, 2026.